Core Viewpoint - Rosen Law Firm is reminding investors who purchased Canopy Growth Corporation securities between May 30, 2024, and February 6, 2025, of the June 3, 2025, lead plaintiff deadline for a class action lawsuit [1]. Group 1: Class Action Details - Investors who purchased Canopy Growth securities during the specified Class Period may be entitled to compensation without any out-of-pocket fees through a contingency fee arrangement [2]. - A class action lawsuit has already been filed, and interested parties must move the Court to serve as lead plaintiff by June 3, 2025 [3]. - Investors can join the class action by visiting the provided link or contacting the law firm directly for more information [6]. Group 2: Law Firm Credentials - Rosen Law Firm emphasizes the importance of selecting qualified counsel with a successful track record in securities class actions, highlighting its own achievements in this area [4]. - The firm has secured significant settlements for investors, including over $438 million in 2019 alone, and has been consistently ranked among the top firms for securities class action settlements [4]. Group 3: Case Allegations - The lawsuit alleges that Canopy Growth made false and misleading statements regarding the costs associated with the launch of its Claybourne product and the impact on its gross margins [5]. - It is claimed that the company overstated the effectiveness of its cost reduction measures while downplaying financial issues, leading to investor damages when the true information became public [5].

Core Viewpoint - A class action securities lawsuit has been filed against Canopy Growth Corporation, alleging securities fraud that negatively impacted investors between May 30, 2024, and February 6, 2025 [1][2]. Group 1: Lawsuit Details - The lawsuit claims that Canopy Growth Corporation made false statements regarding significant costs incurred during the production of Claybourne pre-rolled joints and the launch of the Claybourne product in Canada [2]. - It is alleged that these costs, along with indirect costs related to Storz & Bickel vaporizer devices, would significantly harm the Company's gross margins and overall financial results [2]. - The defendants are accused of overstating the effectiveness of Canopy's cost reduction measures and the health of its gross margins while minimizing related issues [2]. Group 2: Investor Information - Investors who suffered losses during the specified timeframe have until June 3, 2025, to request appointment as lead plaintiff, although participation in any recovery does not require this role [3]. - Class members may be entitled to compensation without any out-of-pocket costs or fees, and there is no obligation to participate [3]. Group 3: Legal Firm Background - Levi & Korsinsky, LLP has a history of securing hundreds of millions of dollars for shareholders and has been recognized as one of the top securities litigation firms in the United States for seven consecutive years [4].

Core Insights - Rubicon Organics Inc. has successfully removed all conditions precedent related to its purchase and sale agreement for the Hope Facility, a 47,500 square foot indoor cultivation facility in British Columbia [1][2][3] - The acquisition is expected to significantly enhance the company's premium production capacity and support its growth strategy, with the first harvest anticipated by the end of 2025 and revenue expected in early 2026 [2][4] Company Overview - Rubicon Organics is a licensed producer focused on cultivating and selling organic certified and premium cannabis products, with a vertically integrated structure through its subsidiary Rubicon Holdings Corp [6][7] - The company aims to achieve industry-leading profitability through its premium cannabis flower, product innovation, and brand portfolio management, which includes flagship brands such as Simply Bare™ Organic, 1964 Supply Co™, Wildflower™, and Homestead Cannabis Supply™ [6][7] Facility Details - The Hope Facility is designed with advanced cultivation technology and is expected to have an annual production capacity of up to 4,500 kilograms [4] - The facility will play a crucial role in expanding Rubicon Organics' premium product offerings to meet rising demand in the market [4][6]

Core Insights - Tilray Medical has launched its cannabis brand Good Supply in Germany, aiming to provide affordable and reliable medical cannabis options for patients [1][2][3] - The introduction of Good Supply reflects Tilray's commitment to enhancing patient care and empowering healthcare professionals with innovative medical cannabis solutions [2][3] - Good Supply offers a variety of cannabis strains, available in both 15g and 500g, catering to the diverse needs of patients [2][7] Company Overview - Tilray Medical is a leading player in the global medical cannabis industry, with operations in Canada, Portugal, and Germany, and is recognized for its commitment to quality and innovation [3][4] - The company has established itself as a trusted supplier of medical cannabis, with a portfolio that includes multiple brands designed to meet patient needs worldwide [4][6] - Tilray Brands, Inc. operates as a global lifestyle and consumer packaged goods company, focusing on cannabis, wellness, and entertainment, with a mission to inspire joy and create memorable experiences [6]

Group 1 - The Cronos Group is recognized as a pioneer in the cannabis industry, known for its strong brands and strategic investment partnerships [1] - The company is experiencing continuous revenue growth and has established itself as a significant player in the market [1] - The investment approach focuses on identifying undervalued businesses with strong fundamentals, aiming to build and preserve generational wealth [1] Group 2 - The investment strategy involves screening approximately 10,000 publicly listed companies to find dominant players in resilient sectors [1] - The emphasis is on companies led by shareholder-aligned management teams that generate strong free cash flows [1]

Core Viewpoint - Blüm Holdings, Inc. is executing a strategic transaction to acquire a 100% membership interest in a holding company that has a non-controlling equity interest in Cookies Creative Consulting & Promotions, Inc., enhancing its alignment with a leading cannabis brand in the U.S. [1] Group 1: Transaction Details - The acquisition will be conducted through a newly formed wholly owned subsidiary, Blüm Acquisition Co., in exchange for 489,131 shares of Blüm common stock and a warrant for an additional 30,762 shares at an exercise price of $0.64 per share, totaling an implied value of $562,500 [2][3] - The share and warrant consideration will be subject to customary adjustments based on the verified ownership percentage of Cookies held by the seller [3] Group 2: Strategic Importance - The CEO of Blüm Holdings emphasized that this transaction is a significant step in the company's long-term strategy to increase economic exposure to major cannabis brands through strategic relationships [4] - The recent transactions are expected to provide exposure to equity value not fully visible in Blüm's public float, including its retail dispensary portfolio and Cookies-branded flagship store [4] Group 3: Future Outlook - The transaction is anticipated to close upon the completion of definitive agreements and customary closing conditions, with a target closing date set for Q3 2025 [4]

Core Viewpoint - Verano Holdings Corp. is expanding its retail presence in Connecticut with the opening of Zen Leaf Enfield, increasing its total dispensary count to 157 nationwide, and actively engaging in community development projects [1][2][5]. Group 1: Company Expansion - Zen Leaf Enfield will officially open on May 23, 2025, marking the seventh retail location for Verano in Connecticut [1]. - The company now operates 157 dispensaries across the United States and has 15 cultivation and processing facilities with over 1.1 million square feet of cultivation capacity [5][9]. Group 2: Community Engagement - Verano is supporting the Thompsonville Fire Department by providing funds for a year's supply of Narcan to aid in combating the opioid crisis [3][5]. - The company is also involved in local charitable initiatives, including a food donation drive for Enfield Loaves and Fishes and Enfield Food Shelf [3][5]. Group 3: Grand Opening Activities - The Grand Opening celebration will feature various activities, including a ceremonial ribbon cutting with community leaders and local partners [6][7]. - Special promotions will be available during the opening weekend, including discounts on cannabis products and complimentary food from local vendors [6][8]. Group 4: Local Economic Development - Zen Leaf Enfield is strategically located near the Enfield Square Mall, which is undergoing a $250 million redevelopment into the Enfield Marketplace, aimed at boosting local economic growth [2][5]. - The company aims to contribute to the long-term success of the Enfield community by investing in local job opportunities [2].

Core Viewpoint - Investing in stocks during market volatility requires a balanced strategy that focuses on growth, dividends, and stability to appeal to long-term investors while managing overall risk Group 1: Dividend Stocks - Allocating $5,000 to a top dividend stock can provide valuable recurring income, which can enhance overall returns and support day-to-day financial needs without liquidating other investments [3][5] - Enbridge (ENB) is highlighted as a strong dividend stock, offering a yield of 6%, significantly higher than the S&P 500 average of 1.3%, resulting in $300 per year in dividends from a $5,000 investment [4][5] - Enbridge has a track record of increasing its dividend for 30 consecutive years, indicating strong financial performance and the likelihood of continued dividend growth in the future [6] Group 2: Growth Stocks - A significant investment of $4,000 is recommended for a growth stock, with Alphabet (GOOG) identified as a suitable option due to its strong assets in YouTube and Google Search, along with heavy investments in artificial intelligence [7][8] - Despite facing antitrust concerns and a 12% decline in stock price in 2025, Alphabet's valuation at 19 times trailing earnings and its generation of $75 billion in free cash flow over the past 12 months presents a compelling investment opportunity [9][10] Group 3: Riskier Investments - The remaining $1,000 can be allocated to a riskier stock with high upside potential, such as Green Thumb Industries (GTBIF), a cannabis company with significant future value potential [11] - Green Thumb operates in 14 states with over 100 retail stores, and potential nationwide marijuana legalization could greatly benefit the company by improving access to funding and market efficiency [12][13] - Although Green Thumb has lost more than half of its value in the past three years due to industry challenges and skepticism about legalization, it remains one of the safer cannabis investments, making it a candidate for a modest position in a diversified portfolio [13][14]

Core Viewpoint - Glass House Brands Inc. is implementing a long-term management incentive plan that includes performance-based restricted stock units (RSUs) for key executives, aimed at aligning their interests with those of shareholders and driving long-term value creation [1][2][6]. Group 1: Management Incentive Plan - The Board of Directors approved a long-term management incentive plan on May 15, 2025, granting performance-based RSUs to key executives, which will vest based on achieving specific share price milestones [2][5]. - The performance-based RSUs will vest over a five-year period, contingent upon the company achieving a minimum share price of $30.00, with additional vesting if the price reaches or exceeds $60.00 [2][3]. - A total of 3,000,000 performance-based RSUs were granted, representing approximately 2.3% of the fully diluted share count as of May 14, 2025 [3]. Group 2: Shareholder Alignment and Governance - The Performance Awards are designed to align the interests of shareholders, the company, and the recipients, encouraging retention of key executives and promoting the achievement of strategic and financial objectives [6][7]. - A special committee of independent directors was established to assess the efficacy of the Performance Awards, ensuring they are in the best interests of the company [5]. - The Board adopted a clawback policy to recover any proceeds from the Performance Awards in the event of financial restatements, consistent with best governance practices [7]. Group 3: Company Overview - Glass House Brands is recognized as one of the fastest-growing, vertically integrated cannabis companies in the U.S., focusing on the California market and building strong brands [8][9]. - The company operates a range of brands and retail dispensaries, emphasizing sustainable practices and community respect [9].

Steve McLean Named Interim Chief Financial OfficerLAS VEGAS, May 20, 2025 (GLOBE NEWSWIRE) -- Planet 13 Holdings Inc. (CSE: PLTH) (OTCQX: PLNH) (“Planet 13” or the “Company”), a leading vertically-integrated multi-state cannabis company, today announced that Dennis Logan, the Chief Financial Officer of the Company, submitted his resignation effective May 31, 2025. Mr. Logan will be leaving the Company to pursue other opportunities. Mr. Logan has served as the Chief Financial Officer of the Company since 20 ...